139 related articles for article (PubMed ID: 807954)
1. Stereoisomeric relationships among anti-inflammatory activity, inhibition of platelet aggregation, and inhibition of prostaglandin synthetase.
Gaut ZN; Baruth H; Randall LO; Ashley C; Paulsrud JR
Prostaglandins; 1975 Jul; 10(1):59-66. PubMed ID: 807954
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandin synthetase activity from human rheumatoid synovial tissue and its inhibition by non-steroidal anti-inflammatory drugs.
Crook D; Collins A,
Prostaglandins; 1975 Jun; 9(6):857-65. PubMed ID: 240190
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological properties of a new anti-inflammatory compound, alpha-(3,5-di-tert-butyl-4-hydroxybenzylidene)-gamma-butyrolacto ne (KME-4), and its inhibitory effects on prostaglandin synthetase and 5-lipoxygenase.
Hidaka T; Hosoe K; Ariki Y; Takeo K; Yamashita T; Katsumi I; Kondo H; Yamashita K; Watanabe K
Jpn J Pharmacol; 1984 Sep; 36(1):77-85. PubMed ID: 6438380
[TBL] [Abstract][Full Text] [Related]
4. Activation of peroxisome proliferator-activated receptor isoforms and inhibition of prostaglandin H(2) synthases by ibuprofen, naproxen, and indomethacin.
Jaradat MS; Wongsud B; Phornchirasilp S; Rangwala SM; Shams G; Sutton M; Romstedt KJ; Noonan DJ; Feller DR
Biochem Pharmacol; 2001 Dec; 62(12):1587-95. PubMed ID: 11755111
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin synthetase systems of rabbit tissues and their inhibition by nonsteroidal anti-inflammatory drugs.
Pong SS; Levine L
J Pharmacol Exp Ther; 1976 Jan; 196(1):226-30. PubMed ID: 812982
[TBL] [Abstract][Full Text] [Related]
6. [The inhibitory effect of oxaprozin, a new non-steroidal anti-inflammatory drug, on platelet aggregation].
Goto J; Muramatsu M; Hosoda K; Otomo S; Aihara H
Nihon Yakurigaku Zasshi; 1984 May; 83(5):395-400. PubMed ID: 6432657
[TBL] [Abstract][Full Text] [Related]
7. The effect of anti-inflammatory agents on human synovial fibroblast prostaglandin synthetase.
Newcombe DS; Ishikawa Y
Prostaglandins; 1976 Nov; 12(5):849-69. PubMed ID: 824687
[TBL] [Abstract][Full Text] [Related]
8. Carrageenan and thrombin trigger prostaglandin synthetase-independent aggregation of rabbit platelets: inhibition by phospholipase A2 inhibitors.
Vargaftig BB
J Pharm Pharmacol; 1977 Apr; 29(4):222-8. PubMed ID: 17672
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandin endoperoxides, thromboxane A2 and adenosine diphosphate in collagen-induced aggregation of rabbit platelets.
Lewis GP; Watts IS
Br J Pharmacol; 1982 Apr; 75(4):623-31. PubMed ID: 6802211
[TBL] [Abstract][Full Text] [Related]
10. Effect of a new anti-inflammatory drug (oxametacine) on the prostaglandin biosynthesis.
Franzone JS; Natale T; Cirillo R
Farmaco Sci; 1980 Jun; 35(6):498-503. PubMed ID: 6778714
[TBL] [Abstract][Full Text] [Related]
11. Differential inhibitory effects of vitamin E and other antioxidants on prostaglandin synthetase, platelet aggregation and lipoxidase.
Panganamala RV; Miller JS; Gwebu ET; Sharma HM; Cornwell DG
Prostaglandins; 1977 Aug; 14(2):261-71. PubMed ID: 408877
[TBL] [Abstract][Full Text] [Related]
12. On the mode of action and biochemical properties of anti-inflammatory drugs-II.
Saeed SA; Cuthbert J
Prostaglandins; 1977 Mar; 13(3):565-75. PubMed ID: 403575
[TBL] [Abstract][Full Text] [Related]
13. Cyclic adenosine 3',5'-monophosphate inhibits the availability of arachidonate to prostaglandin synthetase in human platelet suspensions.
Minkes M; Stanford N; Chi MM; Roth GJ; Raz A; Needleman P; Majerus PW
J Clin Invest; 1977 Mar; 59(3):449-54. PubMed ID: 190267
[TBL] [Abstract][Full Text] [Related]
14. Effects of inhibition of prostaglandin endoperoxide synthase-2 in chronic gastro-intestinal ulcer models in rats.
Schmassmann A; Peskar BM; Stettler C; Netzer P; Stroff T; Flogerzi B; Halter F
Br J Pharmacol; 1998 Mar; 123(5):795-804. PubMed ID: 9535006
[TBL] [Abstract][Full Text] [Related]
15. Lack of covalent modification of prostaglandin synthetase (cyclo-oxygenase) by indomethacin.
Stanford N; Roth GJ; Shen TY; Majerus PW
Prostaglandins; 1977 Apr; 13(4):669-75. PubMed ID: 404672
[TBL] [Abstract][Full Text] [Related]
16. Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides.
Gryglewski RJ; Bunting S; Moncada S; Flower RJ; Vane JR
Prostaglandins; 1976 Nov; 12(5):685-713. PubMed ID: 824685
[TBL] [Abstract][Full Text] [Related]
17. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
[TBL] [Abstract][Full Text] [Related]
18. The antiinflammatory profile of (5H-dibenzo[a,d]-cyclohepten-5-ylidene)acetic acid (WY-41,770), an agent possessing weak prostaglandin synthetase inhibitory activity that is devoid of gastric side effects.
Carlson RP; Datko LJ; Chang J; Nielsen ST; Lewis AJ
Agents Actions; 1984 Jun; 14(5-6):654-61. PubMed ID: 6433676
[TBL] [Abstract][Full Text] [Related]
19. 3-Phenyl-5-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]indole-2-carbonitrile, a potent inhibitor of prostaglandin synthetase and of platelet aggregation.
Fahrenholtz KE; Silverzweig MZ; Germane N; Crowley HJ; Simko BA; Dalton C
J Med Chem; 1979 Aug; 22(8):948-53. PubMed ID: 114655
[TBL] [Abstract][Full Text] [Related]
20. The pharmacological profile of 2-(8-methyl-10,11-dihydro-11-oxodibenz[b,f]oxepin-2-yl)propionic acid (AD-1590), a new non-steroidal anti-inflammatory agent with potent antipyretic activity.
Nakamura H; Yokoyama Y; Motoyoshi S; Ishii K; Imazu C; Seto Y; Kadokawa T; Shimizu M
Arzneimittelforschung; 1983; 33(11):1555-69. PubMed ID: 6607053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
